On, October 12, 2021, Glaxosmithkline announced that, it will move its global headquarters to a new £120m site as the Company prepares to split up its empire into two separate businesses. In addition, the Company stated that it will form a separate company dubbed New GSK by chief executive officer Emma Walmsley.